Applications of genetically manipulated mice in pharmacogenetics and pharmacogenomics

被引：10

作者：

Kimura, S ^{[1
]}

Gonzalez, F ^{[1
]}

机构：

[1] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA

来源：

PHARMACOLOGY | 2000年 / 61卷 / 03期

关键词：

cytochrome P450; xenobiotic-metabolizing enzymes; gene knockout mouse; transgenic mouse; pharmacogenetics; pharmacogenomics;

D O I：

10.1159/000028395

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Gene knockout mice have proven to be very useful in understanding the role of xenobiotic-metabolizing enzymes in chemical toxicity and carcinogenesis, The combination of gene knockout technology with transgenic mouse technology should provide more versatile and suitable animal models to study the risks of chemical exposures in humans in terms of toxicity and carcinogenesis, as well as development and design of new therapeutic drugs, Recent studies using genetically manipulated mice are summarized. Copyright (C) 2000 S. Karger AG. Basel.

引用

收藏

页码：147 / 153

页数：7

相关论文

共 36 条

[1]

[Anonymous], 1994, MANIPULATING MOUSE E

[2] MUTAGEN ACTIVATION BY CDNA-EXPRESSED P1450, P3450, AND P450A [J].

AOYAMA, T ;

GONZALEZ, FJ ;

GELBOIN, HV .

MOLECULAR CARCINOGENESIS, 1989, 1 (04) :253-259

[3] IDENTIFICATION OF A RAT ADRENAL CYTOCHROME-P450 ACTIVE IN POLYCYCLIC-HYDROCARBON METABOLISM AS RAT CYP1B1 - DEMONSTRATION OF A UNIQUE TISSUE-SPECIFIC PATTERN OF HORMONAL AND ARYL-HYDROCARBON RECEPTOR-LINKED REGULATION [J].

BHATTACHARYYA, KK ;

BRAKE, PB ;

ELTOM, SE ;

OTTO, SA ;

JEFCOATE, CR .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) :11595-11602

[4] ACETAMINOPHEN HEPATOTOXICITY [J].

BLACK, M .

ANNUAL REVIEW OF MEDICINE, 1984, 35 :577-593

[5]

BURK RF, 1990, RES COMMUN CHEM PATH, V69, P115

[6] Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas [J].

Buters, JTM ;

Sakai, S ;

Richter, T ;

Pineau, T ;

Alexander, DL ;

Savas, U ;

Doehmer, J ;

Ward, JM ;

Jefcoate, CR ;

Gonzalez, FJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :1977-1982

[7] Role of CYP1A2 in caffeine pharmacokinetics and metabolism: Studies using mice deficient in CYP1A2 [J].

Buters, JTM ;

Tang, BK ;

Pineau, T ;

Gelboin, HV ;

Kimura, S ;

Gonzalez, FJ .

PHARMACOGENETICS, 1996, 6 (04) :291-296

[8] CANCER GENES - SINGLE AND SUSCEPTIBILITY - EXPOSING THE DIFFERENCE [J].

CAPORASO, N ;

GOLDSTEIN, A .

PHARMACOGENETICS, 1995, 5 (02) :59-63

[9] Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: Substrate specificity with model substrates and promutagens [J].

Crespi, CL ;

Penman, BW ;

Steimel, TD ;

Smith, T ;

Yang, CS ;

Sutter, TR .

MUTAGENESIS, 1997, 12 (02) :83-89

[10] ROLE OF CYTOCHROME P4501A2 IN CHEMICAL CARCINOGENESIS - IMPLICATIONS FOR HUMAN VARIABILITY IN EXPRESSION AND ENZYME-ACTIVITY [J].

EATON, DL ;

GALLAGHER, EP ;

BAMMLER, TK ;

KUNZE, KL .

PHARMACOGENETICS, 1995, 5 (05) :259-274

← 1 2 3 4 →